Interaction of alpha1D-adrenergic and P2X(7) receptors in the rat lacrimal gland and the effect on intracellular [Ca2+] and protein secretion

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5720-9. doi: 10.1167/iovs.11-7358.

Abstract

Purpose: To determine whether α(1D)-adrenergic receptors (α(1D)-AR) and P2X(7) receptors interact by determining their effect on ATP release, intracellular [Ca(2+)] ([Ca(2+)](i)), and protein secretion in rat lacrimal gland acini.

Methods: Exorbital lacrimal glands from male Sprague-Dawley rats were divided into pieces or digested with collagenase to form acini. With the use of an imaging system, [Ca(2+)](i) was measured in acini loaded with fura-2. Adenosine triphosphate (ATP) release was determined using the luciferin-luciferase reaction. Peroxidase secretion, our index for protein secretion, was measured spectrophotometrically. Acini were stimulated with the P2X(7) receptor agonist, (benzoylbenzoyl)adenosine 5' triphosphate (BzATP) or the α(1D)-AR agonist phenylephrine with or without antagonist preincubation.

Results: Phenylephrine increased ATP release from pieces in a time-dependent manner. The α(1D)-AR antagonist BMY7378 blocked the BzATP-stimulated increase in [Ca(2+)](i) but not in peroxidase secretion. The P2X(7) antagonist A438079 blocked the phenylephrine-stimulated increase in [Ca(2+)](i) but not peroxidase secretion. The increase in [Ca(2+)](i) caused by phenylephrine and BzATP used simultaneously or sequentially was additive, as was the increase in peroxidase secretion. The inhibition of protein kinase C isoforms or calcium calmodulin kinase II did not alter the BzATP-induced increase in [Ca(2+)](i).

Conclusions: The authors conclude that activation of α(1D)-AR releases ATP, which induces P2X(7) receptors to increase [Ca(2+)](i) but not to stimulate protein secretion. P2X(7) receptors in turn activate α(1D)-AR to increase [Ca(2+)](i) but not to stimulate protein secretion. Furthermore, α(1D)-AR compared with P2X(7) receptors use different cellular mechanisms to increase [Ca(2+)](i) and cause protein secretion.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology
  • Adrenergic alpha-1 Receptor Agonists / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Calcium / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • In Vitro Techniques
  • Lacrimal Apparatus / metabolism*
  • Male
  • Phenylephrine / pharmacology
  • Piperazines / pharmacology
  • Protein Kinase C / metabolism
  • Purinergic P2X Receptor Agonists / pharmacology
  • Purinergic P2X Receptor Antagonists / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor Cross-Talk / drug effects
  • Receptor Cross-Talk / physiology
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Receptors, Purinergic P2X7 / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Tears / metabolism*
  • Tetrazoles / pharmacology

Substances

  • 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine
  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Antagonists
  • Piperazines
  • Purinergic P2X Receptor Agonists
  • Purinergic P2X Receptor Antagonists
  • Pyridines
  • Receptors, Adrenergic, alpha-1
  • Receptors, Purinergic P2X7
  • Tetrazoles
  • Phenylephrine
  • 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate
  • Adenosine Triphosphate
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • BMY 7378
  • Calcium